-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Stock not eligible for rating
| Open | 19.14 |
| Previous Close | 19.05 |
| Volume | 854.00 |
| Value (Lacs) | 0.16 |
| VWAP | 0.00 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 193 |
| High | 19.45 |
| Low | 18.15 |
| UC Limit | 0.00 |
| LC Limit | 0.00 |
| 52 Week High | 25.79 |
| 52 Week Low | 16.15 |
| Face Value | 1.00 |
| All Time High | 780.00 |
| All Time Low | 0.05 |
| 20D Avg Volume | 13,105 |
| 20D Avg Delivery(%) | -- |
| Book Value Per Share | 0.85 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | 0.13 (+1,957.14% YoY) |
| TTM PE See historical trend | 144.08 (Average PE) |
| P/B See historical trend | 22.04 (Low P/B) |
| Sector PE | 30.15 |
*Delayed by 20 seconds.
Stock Score
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
10 out of 17 years State Bank of India has given negative returns in January.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| January | 27.33% (2012) | 9.03% | -19.85% (2016) | -6.81% | -0.87% |
Some market chatter on social media mentions possible regulatory issues in China related to certain Indian pharma APIs, including one product chlorpheniramine maleate API linked to Supriya Lifescience. No official company update so far, so the fall could also be due to general market weakness or profit booking. Best to wait for clarity. View more
Posted by : sree_v
Repost this message
Some market chatter on social media mentions possible regulatory issues in China related to certain Indian pharma APIs, including one product chlorpheniramine maleate API linked to Supriya Lifescience. No official company update so far, so the fall could also be due to general market weakness or profit booking. Best to wait for clarity.
Some market chatter on social media mentions possible regulatory issues in China related to certain Indian pharma APIs, including one product chlorpheniramine maleate API linked to Supriya Lifescience. No official company update so far, so the fall could also be due to general market weakness or profit booking. Best to wait for clarity. View more
Posted by : sree_v
Repost this message
Some market chatter on social media mentions possible regulatory issues in China related to certain Indian pharma APIs, including one product chlorpheniramine maleate API linked to Supriya Lifescience. No official company update so far, so the fall could also be due to general market weakness or profit booking. Best to wait for clarity.
Posted by : The Fixed Income
Repost this message
built with love in india, the fixed income is a sebi registered bond investment platform. it empowers over 2,00,000 investors to grow with stability. whether it’s corporate bonds, government bonds, fixed deposits, or more, our platform helps you build a solid financial foundation with predictable, stable returns. explore now: https://tinyurl.com/fihopa
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
